Amarin Corp Plcuk Asset Turnover Ratio (AMRN), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amarin Corp Plcuk  (NASDAQ: AMRN)
 

Amarin Plcuk Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2026, Amarin Plcuk's asset turnover ratio sequentially decreased to 0.27 in the third quarter (Sep 30 2026), this is lower than usual.

Within sector 119 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 2546, from total ranking in the second quarter 2026 at 3214.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMRN Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -3.93 % -6.83 % -1.51 % -9.47 % -0.56 %
Y / Y Revenue Change -19.87 % -41.63 % 7.41 % -21.01 % 17.43 %
Asset Turnover Ratio (TTM) 0.27 0.28 0.32 0.31 0.32
AMRN's Total Ranking # 2546 # 3214 # 2305 # 2343 #
Seq. Asset Change 1.52 % -3.31 % -14.34 % 14.26 % -1.54 %
Seq. Revenue Change -6.27 % -5.92 % -8.3 % -0.91 % -31.72 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 120
Healthcare Sector # 395
Overall Market # 2546

Asset Turnover Ratio Statistics
High Average Low
1.08 0.54 0.1
(Dec 31 2017)   (Dec 31 2013)




AMRN Company Profile • Back to AMRN Efficiency Comparisons • Compare AMRN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Pulmonx Corporation  0.75 $ 89.176  Millions$ 118.550  Millions
Beone Medicines Ltd   0.74 $ 6,606.279  Millions$ 8,948.433  Millions
Arbutus Biopharma Corp  0.74 $ 181.490  Millions$ 246.376  Millions
Msa Safety Inc  0.73 $ 2,015.730  Millions$ 2,749.546  Millions
Adapthealth Corp   0.73 $ 3,152.043  Millions$ 4,320.541  Millions
Neurocrine Biosciences Inc   0.72 $ 3,701.700  Millions$ 5,131.050  Millions
Tenet Healthcare Corp  0.72 $ 22,154.000  Millions$ 30,787.000  Millions
Strata Critical Medical Inc   0.72 $ 236.425  Millions$ 328.668  Millions
Acadia Pharmaceuticals Inc   0.72 $ 1,202.301  Millions$ 1,676.619  Millions
Gossamer Bio Inc   0.71 $ 78.423  Millions$ 110.588  Millions
Quest Diagnostics Inc  0.71 $ 11,841.000  Millions$ 16,764.500  Millions
Mirum Pharmaceuticals Inc   0.71 $ 670.778  Millions$ 951.331  Millions
Ani Pharmaceuticals Inc  0.70 $ 1,041.343  Millions$ 1,481.030  Millions
3m Company  0.68 $ 25,247.000  Millions$ 36,904.750  Millions
Insmed Inc  0.68 $ 1,479.040  Millions$ 2,167.261  Millions
Illumina Inc   0.68 $ 4,538.000  Millions$ 6,666.250  Millions
Dentsply Sirona Inc   0.68 $ 3,575.000  Millions$ 5,263.000  Millions
Biomerica Inc   0.68 $ 4.338  Millions$ 6.413  Millions
Resmed Inc   0.67 $ 5,743.164  Millions$ 8,534.109  Millions
U S Physical Therapy Inc  0.67 $ 837.629  Millions$ 1,247.671  Millions
Eli Lilly And Company  0.67 $ 86,462.000  Millions$ 129,851.750  Millions
Bridgebio Pharma Inc   0.67 $ 945.540  Millions$ 1,421.523  Millions
Lantheus Holdings Inc   0.66 $ 1,561.890  Millions$ 2,361.195  Millions
Viskase Holdings inc   0.65 $ 271.837  Millions$ 420.742  Millions
Halozyme Therapeutics Inc   0.64 $ 1,802.448  Millions$ 2,812.199  Millions
Glaukos Corp  0.63 $ 578.355  Millions$ 921.716  Millions
Ceribell Inc   0.63 $ 109.203  Millions$ 174.150  Millions
Rhythm Pharmaceuticals Inc   0.62 $ 280.748  Millions$ 450.727  Millions
Sarepta Therapeutics Inc   0.61 $ 1,956.339  Millions$ 3,220.804  Millions
Heron Therapeutics Inc   0.61 $ 149.458  Millions$ 246.201  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.